Washington, DC 20006-5349
HELPLINE
Dr. Raffit Hassan of the National Cancer Institute joins us for a conversation about his study called “Tissue Procurement and Natural History Study of Patients…
(A version of this article was first published in the Mesothelioma Applied Research Foundation’s summer newsletter. The article has been updated with newly available information.)…
In this episode of MesoTV, we are joined by Suellen Crano, a 21-year peritoneal mesothelioma survivor, who shares her story from the early stages of…
This week, Nature Medicine published the results, as well the genomic and immunologic analyses, from the Phase 2 PrE0505 clinical trial. The trial, which took…
We sit down with Chuong D. Hoang, MD, thoracic surgical oncologist at the National Cancer Institute to discuss his new hydrogel based therapy for mesothelioma.…
Dear friends and supporters, We are delighted to report that the Meso Foundation has selected a Patient Services Director to succeed Mary Hesdorffer, who is…
Thanks to the generous support of our patients, families, caregivers, corporate supporters, and the many friends of the Mesothelioma Applied Research Foundation, we are pleased…
Jessica Blackford-Cleeton and Rich Mosca, both members of the mesothelioma community, recently participated in the evaluation of research proposals for funding through the Congressionally Directed…
This is a panel of mesothelioma patients and caregivers about managing costs associated with travel to mesothelioma specialists and clinical trials for treatment. Moderated by…
Today, Bristol Myers Squibb announced new three-year overall survival data from its CheckMate -743 study. These data are based on the clinical trial of nivolumab/ipilimumab…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
